132 research outputs found
Intracardiac Echocardiographic Imaging of the Left Atrial Appendage and Detection of a Peridevice Leak After Device Occlusion
Characteristics of the phenotype of mixed cardiomyopathy in patients with implantable cardioverter-defibrillators
OnlinePublBackground or Purpose The prognosis of mixed cardiomyopathy (CMP) in patients with implanted cardioverter-defbrillators
(ICDs) has not been investigated. We aim to study the demographic, clinical, device therapies and survival characteristics
of mixed CMP in a cohort of patients implanted with a defbrillator.
Methods The term mixed CMP was used to categorise patients with impaired left ventricular ejection fraction attributed to
documented non-ischemic triggers with concomitant moderate coronary artery disease. This is a single center observational
cohort of 526 patients with a mean follow-up of 8.7±3.5 years.
Results There were 42.5% patients with ischemic cardiomyopathy (ICM), 26.9% with non-ischemic cardiomyopathy (NICM) and 30.6% with mixed CMP. Mixed CMP, compared to NICM, was associated with higher mean age
(69.1 ± 9.6 years), atrial fibrillation (55.3%) and greater incidence of comorbidities. The proportion of patients with
mixed CMP receiving device shocks was 23.6%, compared to 18.4% in NICM and 27% in ICM. The VT cycle length
recorded in mixed CMP (281.6 ± 43.1 ms) was comparable with ICM (282.5 ± 44 ms; p = 0.9) and lesser than NICM
(297.7±48.7 ms; p=0.1). All-cause mortality in mixed CMP (21.1%) was similar to ICM (20.1%; p=0.8) and higher
than NICM (15.6%; p = 0.2). The Kaplan–Meier curves revealed hazards of 1.57 (95% CI: 0.91, 2.68) for mixed CMP
compared to NICM.
Conclusion In a cohort of patients with ICD, the group with mixed CMP represents a phenotype predominantly comprised
of the elderly with a higher incidence of comorbidities. Mixed CMP resembles ICM in terms of number of device shocks
and VT cycle length. Trends of long-term prognosis of patients with mixed CMP are worse than NICM and similar to ICM.Deep Chandh Raja, Indira Samarawickrema, Sarat Krishna Menon, Rikvin Singh, Abhinav Mehta, Lukah Q. Tuan, Ulhas Pandurangi, Sanjiv Jain, David J. Callans, Francis E. Marchlinski, Walter P. Abhayaratna, Prashanthan Sanders, Rajeev K. Patha
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation
Objective To investigate changes in quality of life (QoL), cognition and functional status according to arrhythmia recurrence after atrial fibrillation (AF) ablation. Methods We compared QoL, cognition and functional status in patients with recurrent atrial tachycardia (AT)/AF versus those without recurrent AT/AF in the AXAFA-AFNET 5 clinical trial. We also sought to identify factors associated with improvement in QoL and functional status following AF ablation by overall change scores with and without analysis of covariance (ANCOVA). Results Among 518 patients who underwent AF ablation, 154 (29.7%) experienced recurrent AT/AF at 3 months. Patients with recurrent AT/AF had higher mean CHA(2)DS(2)-VASc scores (2.8 vs 2.3, p Conclusions Patients without recurrent AT/AF appear to experience greater improvement in functional status but similar QoL as those with recurrent AT/AF after AF ablation
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary
Ventricular arrhythmias are an important cause of morbidity and mortality and come in a variety of forms, from single premature ventricular complexes to sustained ventricular tachycardia and fibrillation. Rapid developments have taken place over the past decade in our understanding of these arrhythmias and in our ability to diagnose and treat them. The field of catheter ablation has progressed with the development of new methods and tools, and with the publication of large clinical trials. Therefore, global cardiac electrophysiology professional societies undertook to outline recommendations and best practices for these procedures in a document that will update and replace the 2009 EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. An expert writing group, after reviewing and discussing the literature, including a systematic review and meta-analysis published in conjunction with this document, and drawing on their own experience, drafted and voted on recommendations and summarized current knowledge and practice in the field. Each recommendation is presented in knowledge byte format and is accompanied by supportive text and references. Further sections provide a practical synopsis of the various techniques and of the specific ventricular arrhythmia sites and substrates encountered in the electrophysiology lab. The purpose of this document is to help electrophysiologists around the world to appropriately select patients for catheter ablation, to perform procedures in a safe and efficacious manner, and to provide follow-up and adjunctive care in order to obtain the best possible outcomes for patients with ventricular arrhythmias
withdrawn 2017 hrs ehra ecas aphrs solaece expert consensus statement on catheter and surgical ablation of atrial fibrillation
n/
Can We Learn about Ventricular Fibrillation in Man by Studying Animal Models of Defibrillation?
- …